1,3-Diethylbenzimidazolium Triodide in Pharmacotherapy of Chronic Compensated Tonsillopharyngitis

Assessment of TUI success rate in treatment of chronic prostatitis resistant to pharmacotherapy

Introduction: Chronic prostatitis is an obtrusive, annoying and common disease that many people are suffering from it, and it is followed by complicated problems for the patient and the treating physician because of recrudescence of the disease. Materials and Methods: In this interventional study 20 patients with prostatitis, who had no satisfactory answer to the common pharmacotherapy, were s...

Treatment of recurrent tonsillopharyngitis.

Penicillin V has long been regarded as the treatment of choice in streptococcal tonsillitis. This is based on factors such as its good tolerability, generally mild side effects, sustained high activity against-haemolytic streptococci and low cost. Over the years the oral dosage prescribed has gradually increased and a 10 day treatment regimen has become standard in most countries, in order to d...

Chlamydia Trachomatis Tonsillopharyngitis

Reports about the extragenital spread of Chlamydia trachomatis (CT) to oropharynx are limited. We report a male patient with progressive tonsillopharyngitis resistant to amoxicillin/clavulanic acid therapy. The patient presented 9 days after an orogenital and oroanal sexual intercourse with a female sex worker. The microimmunofluorescence revealed CT tonsillopharyngitis, and after completing a ...

Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases.

Differences in pharmacokinetics, pharmacodynamics, and physiology contribute to the phenomenon that women and men frequently respond differently to cardiovascular drugs. Hormonal influences, in addition, can play an important role: for example, the menstrual cycle, menopause, and pregnancy--as a result of fluctuations in concentrations of sexual steroids, and of changes in total body water--can...

Pharmacotherapy of respiratory muscles in chronic obstructive pulmonary disease.